Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study by Perez Botero, J, Ormsby, W.D, Ashrani, A.A, McBane, R.D, Wysokinski, W.E, Patnaik, M.M, Lewis, B.R, Grill, D.E, Pruthi, R.K, Heit, J.A

Get full text